http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2270886-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 1975-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1975-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2270886-A1 |
| titleOfInvention | Medicaments for treating nervous hyperacidity, etc - contg. a psychosedative, an antacid, and an antiflatulent |
| abstract | Medicaments for treating gastric hyperacidity, aerophagy and meteorism associated with emotional stress contain (a) a benzodiazepine-type psychosedative; (b) an antacid; (c) an antiflatulent; and opt. (d) suitable carriers and/or additives. Component (a) is pref. chlordiazepoxide, diazepam, medazepam, bromazepam, cloxazolazepam, lorazepam, oxazepam, oxazolazepam, pyazepam or temazepam. Component (b) is pref. a Gp. I, II or III metal salt, hydroxide or oxide, or a mixt. or coppte. thereof, esp. an Al(OH)3/MgCO3 coppte. and/or MgO. Component (c) is pref. dimethylpolysiloxane ("simethicone"). The (a):(b):(c) wt. ratio is pref. 1:50-1000:10-150, esp. 1:100-700:15-125. Unit doses pref. contain 0.5-5 mg. (a), 500-700 mg. (b) and 75-125 mg. (c). |
| priorityDate | 1974-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.